Award NoticePosted Jul 16, 2025

Hematology Analyzer

Army · W40M MRC0 WEST

Stage
Awarded
NAICS
334516
Value
$401K
Solicitation
W81K00-25-F-A127
Set-aside
No Set aside used
PSC
6550
Place
Fort Irwin, CA, USA
Contact
Kevin Vijayan (kevin.vijayan.civ@health.mil)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation W81K00-25-F-A127 in this department, oldest first.

Early notice
None posted
Solicitation
None posted
Award
  • Jul 16, 2025 · this notice
    Award Notice
    SYSMEX AMERICA, INC · $401K

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Note the winner and the end of the period of performance for the recompete.
  • Follow the agency to see the next notice for this work.

What the notice says

The contract action was not awarded competitively. Sysmex is the only vendor known that can support all requirements set forth in the Statement Of Work (SOW). Sysmex is able to provide 100 uL or less of sample which other competitors are unable to provide. The advantage to the Government is large blood volumes (especially from infants, pediatric patients, or those with limited venous access) that can be difficult, and the Weed facility is very small with limited space. A smaller sample volume requirement allows for complete hematological analysis without compromising the patient. Also, the red… (show all)

uced sample volume can streamline the workflow in laboratories, minimizing handling and reducing the risk of errors associated with sample preparation and transfer. Sysmex offers a 6-part differential which is what the Government requires. A 6-part differential (adding eosinophils, basophils, and lymphocytes subpopulations) offers significantly improved resolution, allowing for more precise identification of specific hematological abnormalities allowing pathologists to see and evaluate differential. It is important for the Government because the pathologist is at William Beaumont in El Paso, TX, and having the ability to send this information over is important. The principle also applies to body fluids. A sources sought was posted on 28 April 2025 with capability statements due on 5 May 2025. Sysmex and Beckman Coulter replied with capabilities statements. Sysmex is fully capable. Beckman Coulter couldn�t meet all requirements from the SOW. Beckman Coulter stated the draft SOW posted with the sources sought notice was specific to a competitor. The contract specialist requested the Beckman Coulter to identify which portion(s) of the draft SOW were vendor specific. The contract specialist contacted the Contracting Officer�s Representative (COR) regarding the issues. The COR stated the SOW cannot be changed without reducing capabilities of the hematology section.

Who won similar work

3 award notices on SAM.gov in the last 24 months. Matched by: Same office (W40M MRC0 WEST), same product/service code (PSC) 6550 and NAICS 334516.

Single-winner award sizes (3): middle half $541K to $3.4M, median $543K; range $539K to $6.3M.

WinnerAwardsValueLast
CEPHEID Sunnyvale CA 94089 USA1$6.3MJul 28, 2026
SYSMEX AMERICA, INC1$543KJun 23, 2025
ORTHO-CLINICAL DIAGNOSTICS, INC · $QDEL · $3.0B1$539KJul 17, 2025

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Investor context
  • $QDEL reported $3.0B revenue in FY2025. The median single-winner award in these 3 past awards, $543K, is under 0.1% of that. 10-K

One award's total value against one year of revenue; many awards are paid over several years.

Latest awards

Competitive landscape

For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Army, Dept of (Corps of Engineers) or Army, Dept of (Other) or Natl Guard since 2024 (0 filings)
  • 0 of their lobbyists list a past Army, Dept of (Corps of Engineers) or Army, Dept of (Other) or Natl Guard job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 32 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 1 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.